Total Funding
40
34
Total FundingPost-IPO Debt raised
Growth Score
-1 pts
Heat Score
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
205947
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
- Tarek Tabsh: Co-Founder
- Clarissa Sowemimo-Coker: Chief Operating Officer & General Counsel
About the Company
Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development.
OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need.
